219 related articles for article (PubMed ID: 7598859)
1. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
Meredith SD; Levine PA; Burns JA; Gaffey MJ; Boyd JC; Weiss LM; Erickson NL; Williams ME
Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):790-4. PubMed ID: 7598859
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer.
Alavi S; Namazie A; Calcaterra TC; Wang MB; Srivatsan ES
Laryngoscope; 1999 Jun; 109(6):874-9. PubMed ID: 10369274
[TBL] [Abstract][Full Text] [Related]
4. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
[TBL] [Abstract][Full Text] [Related]
6. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
Muller D; Millon R; Velten M; Bronner G; Jung G; Engelmann A; Flesch H; Eber M; Methlin G; Abecassis J
Eur J Cancer; 1997 Nov; 33(13):2203-10. PubMed ID: 9470807
[TBL] [Abstract][Full Text] [Related]
7. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
8. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
10. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence.
Fortin A; Guerry M; Guerry R; Talbot M; Parise O; Schwaab G; Bosq J; Bourhis J; Salvatori P; Janot F; Busson P
Clin Cancer Res; 1997 Sep; 3(9):1609-14. PubMed ID: 9815850
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck.
Akervall JA; Jin Y; Wennerberg JP; Zätterström UK; Kjellén E; Mertens F; Willén R; Mandahl N; Heim S; Mitelman F
Cancer; 1995 Sep; 76(5):853-9. PubMed ID: 8625189
[TBL] [Abstract][Full Text] [Related]
14. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
15. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
[TBL] [Abstract][Full Text] [Related]
16. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.
Wang MB; Alavi S; Engstrom M; Lee J; Namazie A; Moatamed F; Srivatsan ES
Anticancer Res; 1999; 19(2A):925-31. PubMed ID: 10368635
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis.
Noorlag R; van Kempen PM; Stegeman I; Koole R; van Es RJ; Willems SM
Virchows Arch; 2015 Apr; 466(4):363-73. PubMed ID: 25663615
[TBL] [Abstract][Full Text] [Related]
18. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue.
Fujii M; Ishiguro R; Yamashita T; Tashiro M
Cancer Lett; 2001 Oct; 172(2):187-92. PubMed ID: 11566495
[TBL] [Abstract][Full Text] [Related]
20. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
Muller D; Millon R; Lidereau R; Engelmann A; Bronner G; Flesch H; Eber M; Methlin G; Abecassis J
Eur J Cancer B Oral Oncol; 1994; 30B(2):113-20. PubMed ID: 8032300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
